WASHINGTON — Will House Democrats set their sights on high drug prices over Russian election hacking? Should drug industry CEOs be checking their mailboxes for subpoenas? Is Bob Casey or Greg Walden the next Orrin Hatch? What about the next Claire McCaskill?

Drug industry executives are no doubt buzzing over many questions in the wake of the Democrats’ takeover of the House. Democrats made health care a central plank of their re-election drive, and they’ve made clear that they’ll leverage their new power to make lots of noise about the high cost of prescription drugs.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • The question RE. Pharmaceuticals ‘hiding’ patents behind a claim of an “Indian tribe’s” ‘sovereign Indian nation’ is easily put to rest…permanently! Demand an answer to this question. It is a simple question. So simple, it is hard:
    “Where is the proclamation ratified by the voters of the United States to amend the United States Constitution to make the health, welfare, safety and benefits of a select group of U.S./State citizens distinguishable because of their “Indian ancestry/race?”

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy